{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:13:59Z","timestamp":1783610039413,"version":"3.55.0"},"reference-count":45,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Over the past two decades, the widespread use of flow diversion stents (FDS) has significantly expanded treatment options for patients with intracranial aneurysms (IA). However, FDS implementation requires antiplatelet therapy (APT), the optimal regimen for which remains undefined. This study aimed to evaluate light transmission aggregometry (LTA) as a routine tool for monitoring antiplatelet therapy during flow diversion to examine whether an LTA-based residual-reactivity cut-off is associated with thromboembolic complications and to assess the agreement between LTA and VerifyNow (VN) P2Y12 reaction units (PRU), rather than to establish definitive safety thresholds. Methods: A retrospective analysis was conducted across two expert centers on 771 patients. Based on selection criteria, 203 IA patients who underwent FDS implantation between 2019 and 2023 with LTA-guided APT (clopidogrel plus aspirin) were included; LTA was used for monitoring in all 203 patients, and a subset of 84 patients additionally underwent VerifyNow testing for method comparison. The primary outcome was clinically significant thromboembolic complications (TECs) leading to a reduction in quality of life by \u22651 point on the modified Rankin scale (mRS). The secondary outcome was intracranial hemorrhage. Results: Among the 203 patients (203 FDS implantations), dual aggregometry control (LTA + VN) was performed in 84 cases. At the 12-month follow-up, complete or near-complete aneurysm occlusion was radiologically confirmed in 83.7% of patients. A favorable functional outcome (mRS \u2264 2) at 12 months was observed in 97.5% of cases. Thromboembolic complications occurred in 7 patients (3.4%) and hemorrhagic complications in 4 (2.0%). On receiver operating characteristic (ROC) analysis, the control-LTA cut-off of 44% showed only weak, statistically non-significant discrimination for thromboembolic events (area under the curve, AUC 0.700, 95% confidence interval, CI 0.479\u20130.920; p = 0.073). In the 84 patients tested with both assays, LTA and VerifyNow PRU correlated only moderately (Spearman\u2019s \u03c1 = 0.51; Pearson\u2019s r = 0.53) and showed wide Bland\u2013Altman limits of agreement, indicating that the two methods are not clinically interchangeable. Conclusions: Routine platelet-function aggregometry may be a useful tool for monitoring APT during flow diversion. In this retrospective cohort, lower residual platelet reactivity on LTA was associated with fewer thromboembolic and hemorrhagic events; however, given the small number of outcome events (n = 7) and an LTA cut-off whose discriminative ability did not reach statistical significance, this association is exploratory and hypothesis-generating rather than an established safety threshold. LTA and VerifyNow PRU were not clinically interchangeable, so no VerifyNow cut-off is proposed. Prospective, adequately powered studies with outcomes stratified directly by each assay are required to define and validate clinically applicable thresholds.<\/jats:p>","DOI":"10.3390\/diagnostics16142155","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:17:51Z","timestamp":1783606671000},"page":"2155","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Light Transmission Aggregometry Versus VerifyNow for Antiplatelet Monitoring in Flow Diversion: A Retrospective Comparative Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3112-6584","authenticated-orcid":false,"given":"Andrey","family":"Petrov","sequence":"first","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"},{"name":"Belostrov Clinic of High Technologies, Clinic Beloostrov, 1, Yukki Urban Settlement, Vsevolozhsk District, Leningrad Region, 188651 Saint Petersburg, Russia"},{"name":"\u00abVedanta\u00bb Medical Center, International School of Medicine, International University of Kyrgyzstan, Bishkek 720054, Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5679-1775","authenticated-orcid":false,"given":"Sergei","family":"Ermakov","sequence":"additional","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"},{"name":"Belostrov Clinic of High Technologies, Clinic Beloostrov, 1, Yukki Urban Settlement, Vsevolozhsk District, Leningrad Region, 188651 Saint Petersburg, Russia"},{"name":"Stavropol Krai State Budgetary Healthcare Institution \u201cStavropol Krai Clinical Hospital\u201d, Semashko St., 1, 355030 Stavropol, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Kornev","sequence":"additional","affiliation":[{"name":"Stavropol Krai State Budgetary Healthcare Institution \u201cStavropol Krai Clinical Hospital\u201d, Semashko St., 1, 355030 Stavropol, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Belokon","sequence":"additional","affiliation":[{"name":"Stavropol Krai State Budgetary Healthcare Institution \u201cStavropol Krai Clinical Hospital\u201d, Semashko St., 1, 355030 Stavropol, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Sharshebaev","sequence":"additional","affiliation":[{"name":"\u00abVedanta\u00bb Medical Center, International School of Medicine, International University of Kyrgyzstan, Bishkek 720054, Kyrgyzstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Eliseev","sequence":"additional","affiliation":[{"name":"Stavropol Krai State Budgetary Healthcare Institution \u201cStavropol Krai Clinical Hospital\u201d, Semashko St., 1, 355030 Stavropol, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8595-6666","authenticated-orcid":false,"given":"Natalia","family":"Dryagina","sequence":"additional","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-0391","authenticated-orcid":false,"given":"Arkady","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Petrova","sequence":"additional","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-0249","authenticated-orcid":false,"given":"Konstantin","family":"Samochernykh","sequence":"additional","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-460X","authenticated-orcid":false,"given":"Larisa","family":"Rozhchenko","sequence":"additional","affiliation":[{"name":"Vascular Neurosurgery Department, Polenov Neurosurgical Research Institute, Branch of Almazov National Medical Research Centre, 191014 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clineuro.2017.08.003","article-title":"Flow Diversion with the Pipeline Embolization Device for Patients with Intracranial Aneurysms and Antiplatelet Therapy: A Systematic Literature Review","volume":"161","author":"Texakalidis","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1016\/j.wneu.2019.10.179","article-title":"Preoperative Light Transmission Aggregometry Values Predict for Thromboembolic Complications After Stent-Assisted Coil Embolization","volume":"134","author":"Kan","year":"2020","journal-title":"World Neurosurg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3174\/ajnr.A8352","article-title":"Multicenter Experience with the Pipeline Flex and Vantage with Shield Technology for Intracranial Aneurysm Treatment","volume":"45","author":"Goertz","year":"2024","journal-title":"Am. J. Neuroradiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/neurintsurg-2020-016043","article-title":"Preclinical Safety and Efficacy Evaluation of the Pipeline Vantage Embolization Device with Shield Technology","volume":"12","author":"Starke","year":"2020","journal-title":"J. Neurointerv. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1591019920939845","article-title":"Initial Experience with the Novel P64MW HPC Flow Diverter from a Cohort Study in Unruptured Anterior Circulation Aneurysms under Dual Antiplatelet Medication","volume":"27","author":"Petrov","year":"2021","journal-title":"Interv. Neuroradiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s42155-024-00482-2","article-title":"Outcome of Tailored Antiplatelet Therapy in Carotid Stenting: A Retrospective Comparative Study","volume":"7","author":"Smolka","year":"2024","journal-title":"CVIR Endovasc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/svn-2022-001720","article-title":"Roles of Light Transmission Aggregometry and CYP2C19 Genotype in Predicting Ischaemic Complications during Interventional Therapy for Intracranial Aneurysms","volume":"8","author":"Zhou","year":"2023","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11599070-000000000-00000","article-title":"Antiplatelet Therapy for Prevention of Thromboembolic Complications Associated with Coil Embolization of Unruptured Cerebral Aneurysms","volume":"12","author":"Matsumoto","year":"2012","journal-title":"Drugs R&D"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/j.wneu.2020.03.046","article-title":"Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for Complex Cerebral Aneurysms","volume":"138","author":"Neyens","year":"2020","journal-title":"World Neurosurg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3174\/ajnr.A3621","article-title":"Last-Recorded P2Y12 Reaction Units Value Is Strongly Associated with Thromboembolic and Hemorrhagic Complications Occurring up to 6 Months after Treatment in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device","volume":"35","author":"Crandall","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of Blood Platelets by Adenosine Diphosphate and Its Reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jcp.14.2.140","article-title":"The Adhesiveness of Native Platelets and Its Prevention","volume":"14","year":"1961","journal-title":"J. Clin. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1538-7836.2008.02891.x","article-title":"Standardization of Light Transmittance Aggregometry for Monitoring Antiplatelet Therapy: An Adjustment for Platelet Count Is Not Necessary","volume":"6","author":"Linnemann","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC\/ISTH","volume":"11","author":"Cattaneo","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/jnis-2022-019844","article-title":"Antiplatelets and Antithrombotics in Neurointerventional Procedures: Guideline Update","volume":"15","author":"Schirmer","year":"2023","journal-title":"J. Neurointerv. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ahj.2009.01.003","article-title":"Comparison of Ticagrelor, the First Reversible Oral P2Y(12) Receptor Antagonist, with Clopidogrel in Patients with Acute Coronary Syndromes: Rationale, Design, and Baseline Characteristics of the PLATelet Inhibition and Patient Outcomes (PLATO) Trial","volume":"157","author":"James","year":"2009","journal-title":"Am. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2010.07.038","article-title":"Rationale and Design of the Dual Antiplatelet Therapy Study, a Prospective, Multicenter, Randomized, Double-Blind Trial to Assess the Effectiveness and Safety of 12 versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention with Either Drug-Eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions","volume":"160","author":"Mauri","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_19","first-page":"e43899","article-title":"Anticoagulation Options for Cranial Procedures: A Comparative Review of Aspirin, Plavix, and Aggrastat","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"key":"ref_20","first-page":"184","article-title":"Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?","volume":"3","author":"Alderazi","year":"2015","journal-title":"Interv. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3174\/ajnr.A4411","article-title":"Platelet Testing Is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device","volume":"36","author":"Brinjikji","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/15910199211015042","article-title":"P2Y12 Inhibitors for the Neurointerventionalist","volume":"28","author":"Borchert","year":"2022","journal-title":"Interv. Neuroradiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1538-7836.2007.02775.x","article-title":"Common Polymorphisms of CYP2C19 and CYP2C9 Affect the Pharmacokinetic and Pharmacodynamic Response to Clopidogrel but Not Prasugrel","volume":"5","author":"Brandt","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3171\/2017.5.JNS162307","article-title":"Management of Antiplatelet Therapy in Patients Undergoing Neuroendovascular Procedures","volume":"129","author":"Kim","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.wneu.2024.02.013","article-title":"Ticagrelor Versus Clopidogrel in Endovascular Therapy for Cerebral Aneurysms: A Systematic Review and Meta-Analysis","volume":"184","author":"Saha","year":"2024","journal-title":"World Neurosurg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/neurintsurg-2021-017638","article-title":"Ticagrelor Resistance: A Case Series and Algorithm for Management of Non-Responders","volume":"14","author":"Laurent","year":"2022","journal-title":"J. Neurointerv. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1016\/j.wneu.2022.11.102","article-title":"Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Unruptured Intracranial Aneurysm Treated with Stent-Assisted Coil Embolization: A Single-Center Cohort Study","volume":"170","author":"Yi","year":"2023","journal-title":"World Neurosurg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3174\/ajnr.A7216","article-title":"Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study","volume":"42","author":"Park","year":"2021","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1591019916669090","article-title":"Prasugrel versus Clopidogrel in Stent-Assisted Coil Embolization of Unruptured Intracranial Aneurysms","volume":"23","author":"Sedat","year":"2017","journal-title":"Interv. Neuroradiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2019.01.005","article-title":"Efficacy and Safety of Prasugrel Therapy for Intracranial Aneurysms with Endovascular Treatment: A Meta-Analysis","volume":"397","author":"Xia","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMp1400788","article-title":"Genotype-Phenotype Correlation--Promiscuity in the Era of next-Generation Sequencing","volume":"371","author":"Lu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/gim.2018.39","article-title":"Whole-Exome Sequencing Reanalysis at 12 Months Boosts Diagnosis and Is Cost-Effective When Applied Early in Mendelian Disorders","volume":"20","author":"Ewans","year":"2018","journal-title":"Genet. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1757-7241-21-29","article-title":"Thrombelastography (TEG\u00ae): Practical Considerations on Its Clinical Use in Trauma Resuscitation","volume":"21","author":"Nascimento","year":"2013","journal-title":"Scand. J. Trauma Resusc. Emerg. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/978-1-4939-7196-1_39","article-title":"Thromboelastography (TEG)","volume":"1646","author":"Othman","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/978-1-0716-3175-1_50","article-title":"The Quantra System: System Description and Protocols for Measurements","volume":"2663","author":"Volod","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1515\/cti-2022-0010","article-title":"Basic Principle and Good Practices of Rheology for Polymers for Teachers and Beginners","volume":"4","author":"Ramli","year":"2022","journal-title":"Chem. Teach. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/a-2117-4614","article-title":"Classic Light Transmission Platelet Aggregometry: Do We Still Need It?","volume":"44","author":"Gebetsberger","year":"2024","journal-title":"Hamostaseologie"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/STROKEAHA.116.015308","article-title":"Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study","volume":"48","author":"Adeeb","year":"2017","journal-title":"Stroke"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3171\/2024.3.JNS2487","article-title":"Defining Light Transmission Aggregometry Cutoff Values for Clopidogrel and Aspirin Resistance in Flow Diversion Treatment of Intracranial Aneurysms","volume":"141","author":"Filo","year":"2024","journal-title":"J. Neurosurg."},{"key":"ref_40","first-page":"1","article-title":"Lo Studio GRAVITAS","volume":"13","author":"Rollini","year":"2012","journal-title":"G. Ital. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/CIRCULATIONAHA.107.696732","article-title":"Bedside Evaluation of Thienopyridine Antiplatelet Therapy","volume":"119","author":"Price","year":"2009","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic Significance of Post-Clopidogrel Platelet Reactivity Assessed by a Point-of-Care Assay on Thrombotic Events after Drug-Eluting Stent Implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","article-title":"Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention Results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study","volume":"52","author":"Patti","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1136\/neurintsurg-2012-010582","article-title":"Pre-Procedure P2Y12 Reaction Units Value Predicts Perioperative Thromboembolic and Hemorrhagic Complications in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device","volume":"5","author":"Crandall","year":"2013","journal-title":"J. Neurointerv. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/15910199211029503","article-title":"Early Clinical Experience with the P48MW HPC and P64MW HPC Flow Diverters in the Anterior Circulation Aneurysm Using Single Anti-Platelet Treatment","volume":"28","author":"Bhogal","year":"2022","journal-title":"Interv. Neuroradiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/14\/2155\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:25:55Z","timestamp":1783607155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/14\/2155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":45,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16142155"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16142155","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}